Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Consolidated Statements of Operations [Abstract]
Fee income	$ 1,598,799	$ 2,161,359	$ 1,957,336
Operating expenses	4,425,718	6,036,792	4,101,592
Research and development	1,621,964	2,203,326	1,671,872
Total Expenses	6,047,682	8,240,118	5,773,464
Operating loss	(4,448,883)	(6,078,759)	(3,816,128)
Net investment income	35,161	38,148	33,171
Loss before income tax benefit	(4,413,722)	(6,040,611)	(3,782,957)
Income tax benefit			613,397
Net loss	$ (4,413,722)	$ (6,040,611)	$ (3,169,560)
Basic and diluted net loss per common share	$ (0.19)	$ (0.26)	$ (0.16)
Basic and diluted weighted average number of common shares outstanding	23,663,229	22,946,019	20,125,309